readthroughSign in
CompanyGERNNasdaqFoster City, CA

Geron Corporation

Geron develops RYTELO (imetelstat), an oligonucleotide telomerase inhibitor approved in the U.S.

10-QNov 12Latest SEC filing
Nov 6Latest story